ONPH ONPH

Oncology Pharma (PK) Stock Price

3.835
0.175 (4.78%)
3.835
Volume 92,254
Bid Price 3.71
Ask Price 3.80
News -
Day High 3.93

Low
1.00

52 Week Range

High
50.00

Day Low 3.63
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Oncology Pharma Inc (PK) ONPH OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.175 4.78% 3.835 16:02:55
Open Price Low Price High Price Close Price Prev Close
3.65 3.63 3.93 3.835 3.66
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
264 92,254 $ 3.8446 $ 354,678 - 1.00 - 50.00
Last Trade Time Type Quantity Stock Price Currency
16:41:16 14 $ 3.80 USD

Period:

Draw Mode:

Oncology Pharma Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 108.10M 28.19M 3.39M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
13.38k $ - - - -

more financials information »

Oncology Pharma (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ONPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.954.083.603.7391,260-0.115-2.91%
1 Month4.476.003.604.49146,914-0.635-14.21%
3 Months10.5314.122.856.54239,644-6.70-63.58%
6 Months26.0528.572.8511.82266,331-22.22-85.28%
1 Year1.1550.001.0017.34216,9992.69233.48%
3 Years0.0150.000.0036.48246,3723.8338,250.0%
5 Years0.0150.000.0036.48246,3723.8338,250.0%

Oncology Pharma (PK) Description

Oncology Pharma, Inc. is a pioneering oncology company dedicated to licensing, developing, manufacturing and commercializing therapeutics and opportunities within the bio-pharma space. The Company has assembled a team of executives and advisors with a proven multi-disciplinary expertise in the field of cancer therapies, epidemiology and leadership to identify, negotiate and amalgamate "best in class" research, technologies, and drug delivery that are synergistic and collaborative. Oncology Pharma has executed Licensing Agreements with NanoSmart Pharmaceuticals' drug delivery platform, which can target many types of cancer and other diseases;Connect2Med, a powerful application used for recruiting, enrolling and supporting patients for clinical trials. Further information may be found at www.oncology-pharma.com.


Your Recent History
USOTC
ONPH
Oncology P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.